| Delivering the messenger: advances in technologies for therapeutic mRNA delivery PS Kowalski, A Rudra, L Miao, DG Anderson Molecular Therapy 27 (4), 710-728, 2019 | 931 | 2019 |
| mRNA vaccine for cancer immunotherapy L Miao, Y Zhang, L Huang Molecular cancer 20 (1), 41, 2021 | 645 | 2021 |
| Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation L Miao, L Li, Y Huang, D Delcassian, J Chahal, J Han, Y Shi, K Sadtler, ... Nature biotechnology 37 (10), 1174-1185, 2019 | 522 | 2019 |
| Self-assembled redox dual-responsive prodrug-nanosystem formed by single thioether-bridged paclitaxel-fatty acid conjugate for cancer chemotherapy C Luo, J Sun, D Liu, B Sun, L Miao, S Musetti, J Li, X Han, Y Du, L Li, ... Nano letters 16 (9), 5401-5408, 2016 | 387 | 2016 |
| Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer L Liu, Y Wang, L Miao, Q Liu, S Musetti, J Li, L Huang Molecular Therapy 26 (1), 45-55, 2018 | 320 | 2018 |
| Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles K Hu, L Miao, TJ Goodwin, J Li, Q Liu, L Huang ACS nano 11 (5), 4916-4925, 2017 | 245 | 2017 |
| Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors L Miao, CM Lin, L Huang Journal of Controlled Release 219, 192-204, 2015 | 237 | 2015 |
| A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer N Cheng, R Watkins-Schulz, RD Junkins, CN David, BM Johnson, ... JCI insight 3 (22), 2018 | 233 | 2018 |
| Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver L Miao, J Lin, Y Huang, L Li, D Delcassian, Y Ge, Y Shi, DG Anderson Nature communications 11 (1), 2424, 2020 | 232 | 2020 |
| Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors L Miao, Q Liu, CM Lin, C Luo, Y Wang, L Liu, W Yin, S Hu, WY Kim, ... Cancer research 77 (3), 719-731, 2017 | 213 | 2017 |
| Delivery of oligonucleotides with lipid nanoparticles Y Wang, L Miao, A Satterlee, L Huang Advanced drug delivery reviews 87, 68-80, 2015 | 204 | 2015 |
| Esterase‐activated charge‐reversal polymer for fibroblast‐exempt cancer gene therapy N Qiu, X Liu, Y Zhong, Z Zhou, Y Piao, L Miao, Q Zhang, J Tang, L Huang, ... Advanced Materials 28 (48), 10613-10622, 2016 | 202 | 2016 |
| Nanoparticles with precise ratiometric co‐loading and co‐delivery of gemcitabine monophosphate and cisplatin for treatment of bladder cancer L Miao, S Guo, J Zhang, WY Kim, L Huang Advanced functional materials 24 (42), 6601-6611, 2014 | 189 | 2014 |
| The binding site barrier elicited by tumor-associated fibroblasts interferes disposition of nanoparticles in stroma-vessel type tumors L Miao, JM Newby, CM Lin, L Zhang, F Xu, WY Kim, MG Forest, SK Lai, ... ACS nano 10 (10), 9243-9258, 2016 | 185 | 2016 |
| Co-delivery of cisplatin and rapamycin for enhanced anticancer therapy through synergistic effects and microenvironment modulation S Guo, CM Lin, Z Xu, L Miao, Y Wang, L Huang ACS nano 8 (5), 4996-5009, 2014 | 179 | 2014 |
| mRNA vaccine with antigen-specific checkpoint blockade induces an enhanced immune response against established melanoma Y Wang, L Zhang, Z Xu, L Miao, L Huang Molecular Therapy 26 (2), 420-434, 2018 | 172 | 2018 |
| Nanoformulations for combination or cascade anticancer therapy L Miao, S Guo, CM Lin, Q Liu, L Huang Advanced drug delivery reviews 115, 3-22, 2017 | 165 | 2017 |
| PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery Y Zhao, W Wang, S Guo, Y Wang, L Miao, Y Xiong, L Huang Nature communications 7 (1), 11822, 2016 | 162 | 2016 |
| Facile fabrication of tumor redox‐sensitive nanoassemblies of small‐molecule oleate prodrug as potent chemotherapeutic nanomedicine C Luo, J Sun, B Sun, D Liu, L Miao, TJ Goodwin, L Huang, Z He Small 12 (46), 6353-6362, 2016 | 155 | 2016 |
| Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy X Lu, L Miao, W Gao, Z Chen, KJ McHugh, Y Sun, Z Tochka, S Tomasic, ... Science translational medicine 12 (556), eaaz6606, 2020 | 148 | 2020 |
